constructed an s‐PGEA‐FA/miRNA nanocomplex for targeted delivery of miR‐101 and miR‐217 to silence MALAT1 in esophageal squamous cell carcinoma (ESCC) cells, achieving effective inhibition of ESCC progression.[46] Nicola et al. Here, MALAT1 is linked to esophageal squamous cell carcinoma.